Hoogland, E R Pieter <br/><br/>
The value of machine perfusion biomarker concentration in DCD kidney transplantations.  [electronic resource] 

 -  Transplantation  Feb 2013 
 - 603-10 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1534-6080 
<br/><br/><label>Standard No.: </label>10.1097/TP.0b013e31827908e6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute-Phase Proteins--analysis<br/>Adult<br/>Biomarkers--analysis<br/>Delayed Graft Function--etiology<br/>Fatty Acid Binding Protein 3<br/>Fatty Acid-Binding Proteins--analysis<br/>Female<br/>Glutathione Transferase--analysis<br/>Graft Survival<br/>Humans<br/>Interleukin-18--analysis<br/>Iron--analysis<br/>Kaplan-Meier Estimate<br/>Kidney Transplantation--adverse effects<br/>L-Lactate Dehydrogenase--analysis<br/>Lipocalin-2<br/>Lipocalins--analysis<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Nephrectomy<br/>Odds Ratio<br/>Organ Preservation--adverse effects<br/>Organ Preservation Solutions--chemistry<br/>Oxidation-Reduction<br/>Perfusion--adverse effects<br/>Predictive Value of Tests<br/>Proportional Hazards Models<br/>Proto-Oncogene Proteins--analysis<br/>ROC Curve<br/>Risk Assessment<br/>Risk Factors<br/>Time Factors<br/>Treatment Outcome